Allogeneic HCT with Reduced Intensity Conditioning Versus Autologous HCT for >55 Years Old Patients with Acute Lymphoblastic Leukemia in First Complete Remission: An Analysis from Acute Leukemia Working Party of the EBMT

Konference: 2014 56th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 731. Clinical Autologous Transplantation: Results: Poster III

Číslo abstraktu: 3974

Autoři: Sebastian Giebel; MD Myriam Labopin, MS; MD Norbet Claude Gorin; MD Noel-Jean Milpied, Ph.D.; MD Eefke J Petersen, PhD; MD Michael N Potter, PhD; MD Jan Cornelissen, PhD; MD Denis Caillot; MD Dietger W Niederwieser; Rovira Montserrat; MUDr. Pavel Jindra, Ph.D.; MD Ellen Meijer, PhD; M.D. Johan Maertens, Ph.D.; M.D. Alessandro Rambaldi; MD Arnon Nagler, MSc.; MD Mohamad Mohty, PhD

Datum přednesení příspěvku: 8. 12. 2014